Email Newsletter icon, E-mail Newsletter icon, Email List icon, E-mail List icon Sign up for Email Updates
For Email Marketing you can trust

Altus Research

4671 S Congress Avenue
Suite 100-B
Lake Worth, FL 33461

4631 N Congress Avenue
Suite 102
West Palm Beach, FL 33407

fill fill fill

Expanding Treatment for Psoriasis Aims to Ease Patient Dissatisfaction

ON NOVEMBER 10, 2013 by Samuel Lederma


For all its significant leaps throughout history, modern medicine has yet to find a cure for a number of diseases; among them psoriasis. This scaly-skinned menace continues to plague around 7.5 million Americans, with the number still on the rise. Unless an effective cure is found, psoriasis control and treatment will only be as good as keeping it and its effects at bay.

This is all the more reason for research on treatment for psoriasis to step its game up. Reuters reports that at least half of psoriasis patients aren't satisfied with the treatments in use today.

Between 2003 and 2011, more than 5,000 psoriasis or psoriatic arthritis patients in the U.S. filled out surveys about prescription medication use and treatment satisfaction for the National Psoriasis Foundation.

Depending on the year, between nine and 30 percent of the almost 1,900 people with severe psoriasis were not receiving treatment, with higher percentages for mild and moderate psoriasis.

Just over half of psoriasis patients and 45 percent of those with psoriatic arthritis reported being dissatisfied with their treatment, according to results published in JAMA Dermatology.

Treatment for psoriasis usually involve creams, oral or injected medications, and light therapy. Depending on the severity of psoriasis, doctors can prescribe a combination of two or all treatments. However, the effectiveness of intravenous medication was raised in the report, as many psoriasis patients stopped taking it since it wasn't producing its intended effect.

Most people who stopped taking newer injectable and intravenous drugs reportedly did so due to side effects or because the medication wasn't working.

In this case, is medicine fighting a war it can't win? For Dr. Mark Lebwohl of the National Psoriasis Foundation (NSF), there's still reason to cling to hope. Topical treatments and drugs have evolved and expanded in number over the past several years, he said. Today, scientists are closer to finding a way to deal with psoriasis than they were several years ago.

Psoriasis patients will be the key for the continuous evolution of treatment. With actual patients, the researchers can conduct tests on different plausible treatments in a controlled environment. Research facilities like Altus Research are at the forefront of expanding psoriasis and uterine fibroid treatment. For now, tried-and-tested treatments will have to do.

Article Excerpt and Image from Many Psoriasis Patients Dissatisfied with Treatment, Reuters, August 23, 2013)

CATEGORY: Industry News